Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Author Correction: Immune evasion of Borrelia miyamotoi: CbiA, a novel outer surface protein exhibiting complement binding and inactivating properties.

Röttgerding F, Wagemakers A, Koetsveld J, Fingerle V, Kirschfink M, Hovius JW, Zipfel PF, Wallich R, Kraiczy P.

Sci Rep. 2019 May 2;9(1):7056. doi: 10.1038/s41598-019-42948-7.

2.

First insights in the variability of Borrelia recurrentis genomes.

Marosevic D, Margos G, Wallich R, Wieser A, Sing A, Fingerle V.

PLoS Negl Trop Dis. 2017 Sep 13;11(9):e0005865. doi: 10.1371/journal.pntd.0005865. eCollection 2017 Sep.

3.

Immune evasion of Borrelia miyamotoi: CbiA, a novel outer surface protein exhibiting complement binding and inactivating properties.

Röttgerding F, Wagemakers A, Koetsveld J, Fingerle V, Kirschfink M, Hovius JW, Zipfel PF, Wallich R, Kraiczy P.

Sci Rep. 2017 Mar 22;7(1):303. doi: 10.1038/s41598-017-00412-4. Erratum in: Sci Rep. 2019 May 2;9(1):7056.

4.

CipA of Acinetobacter baumannii Is a Novel Plasminogen Binding and Complement Inhibitory Protein.

Koenigs A, Stahl J, Averhoff B, Göttig S, Wichelhaus TA, Wallich R, Zipfel PF, Kraiczy P.

J Infect Dis. 2016 May 1;213(9):1388-99. doi: 10.1093/infdis/jiv601. Epub 2015 Dec 17.

PMID:
26681776
5.

Identification and characterization of a unique role for EDB fibronectin in phagocytosis.

Kraft S, Klemis V, Sens C, Lenhard T, Jacobi C, Samstag Y, Wabnitz G, Kirschfink M, Wallich R, Hänsch GM, Nakchbandi IA.

J Mol Med (Berl). 2016 May;94(5):567-81. doi: 10.1007/s00109-015-1373-0. Epub 2015 Dec 5.

6.

BGA66 and BGA71 facilitate complement resistance of Borrelia bavariensis by inhibiting assembly of the membrane attack complex.

Hammerschmidt C, Klevenhaus Y, Koenigs A, Hallström T, Fingerle V, Skerka C, Pos KM, Zipfel PF, Wallich R, Kraiczy P.

Mol Microbiol. 2016 Jan;99(2):407-24. doi: 10.1111/mmi.13239. Epub 2015 Oct 27.

7.

Whole-Chain Tick Saliva Proteins Presented on Hepatitis B Virus Capsid-Like Particles Induce High-Titered Antibodies with Neutralizing Potential.

Kolb P, Wallich R, Nassal M.

PLoS One. 2015 Sep 9;10(9):e0136180. doi: 10.1371/journal.pone.0136180. eCollection 2015.

8.

Nanoscopic Localization of Surface-Exposed Antigens of Borrelia burgdorferi.

Lemgruber L, Sant'Anna C, Griffths C, Abud Y, Mhlanga M, Wallich R, Frischknecht F.

Microsc Microanal. 2015 Jun;21(3):680-8. doi: 10.1017/S1431927615000318. Epub 2015 Mar 5.

PMID:
25739645
9.

Soluble cysteine-rich tick saliva proteins Salp15 and Iric-1 from E. coli.

Kolb P, Vorreiter J, Habicht J, Bentrop D, Wallich R, Nassal M.

FEBS Open Bio. 2014 Dec 24;5:42-55. doi: 10.1016/j.fob.2014.12.002. eCollection 2015.

10.

Candida albicans uses the surface protein Gpm1 to attach to human endothelial cells and to keratinocytes via the adhesive protein vitronectin.

Lopez CM, Wallich R, Riesbeck K, Skerka C, Zipfel PF.

PLoS One. 2014 Mar 13;9(3):e90796. doi: 10.1371/journal.pone.0090796. eCollection 2014.

11.

Human factor H-related protein 2 (CFHR2) regulates complement activation.

Eberhardt HU, Buhlmann D, Hortschansky P, Chen Q, Böhm S, Kemper MJ, Wallich R, Hartmann A, Hallström T, Zipfel PF, Skerka C.

PLoS One. 2013 Nov 18;8(11):e78617. doi: 10.1371/journal.pone.0078617. eCollection 2013.

12.

Versatile roles of CspA orthologs in complement inactivation of serum-resistant Lyme disease spirochetes.

Hammerschmidt C, Koenigs A, Siegel C, Hallström T, Skerka C, Wallich R, Zipfel PF, Kraiczy P.

Infect Immun. 2014 Jan;82(1):380-92. doi: 10.1128/IAI.01094-13. Epub 2013 Nov 4.

13.

BBA70 of Borrelia burgdorferi is a novel plasminogen-binding protein.

Koenigs A, Hammerschmidt C, Jutras BL, Pogoryelov D, Barthel D, Skerka C, Kugelstadt D, Wallich R, Stevenson B, Zipfel PF, Kraiczy P.

J Biol Chem. 2013 Aug 30;288(35):25229-43. doi: 10.1074/jbc.M112.413872. Epub 2013 Jul 16.

14.

Further structural insights into the binding of complement factor H by complement regulator-acquiring surface protein 1 (CspA) of Borrelia burgdorferi.

Caesar JJ, Wallich R, Kraiczy P, Zipfel PF, Lea SM.

Acta Crystallogr Sect F Struct Biol Cryst Commun. 2013 Jun;69(Pt 6):629-33. doi: 10.1107/S1744309113012748. Epub 2013 May 23.

15.

Mapping the ligand-binding region of Borrelia hermsii fibronectin-binding protein.

Brenner C, Bomans K, Habicht J, Simon MM, Wallich R.

PLoS One. 2013 May 2;8(5):e63437. doi: 10.1371/journal.pone.0063437. Print 2013.

16.

Borrelia valaisiana resist complement-mediated killing independently of the recruitment of immune regulators and inactivation of complement components.

Schwab J, Hammerschmidt C, Richter D, Skerka C, Matuschka FR, Wallich R, Zipfel PF, Kraiczy P.

PLoS One. 2013;8(1):e53659. doi: 10.1371/journal.pone.0053659. Epub 2013 Jan 8.

17.

Interleukin-1R signaling is essential for induction of proapoptotic CD8 T cells, viral clearance, and pathology during lymphocytic choriomeningitis virus infection in mice.

Joeckel LT, Wallich R, Metkar SS, Froelich CJ, Simon MM, Borner C.

J Virol. 2012 Aug;86(16):8713-9. doi: 10.1128/JVI.00682-12. Epub 2012 Jun 6.

18.

Contribution of the infection-associated complement regulator-acquiring surface protein 4 (ErpC) to complement resistance of Borrelia burgdorferi.

Hammerschmidt C, Hallström T, Skerka C, Wallich R, Stevenson B, Zipfel PF, Kraiczy P.

Clin Dev Immunol. 2012;2012:349657. doi: 10.1155/2012/349657. Epub 2012 Jan 30.

19.

Bioactive reagents used in mesotherapy for skin rejuvenation in vivo induce diverse physiological processes in human skin fibroblasts in vitro- a pilot study.

Jäger C, Brenner C, Habicht J, Wallich R.

Exp Dermatol. 2012 Jan;21(1):72-5. doi: 10.1111/j.1600-0625.2011.01400.x.

PMID:
22151394
20.

Mouse granzyme K has pro-inflammatory potential.

Joeckel LT, Wallich R, Martin P, Sanchez-Martinez D, Weber FC, Martin SF, Borner C, Pardo J, Froelich C, Simon MM.

Cell Death Differ. 2011 Jul;18(7):1112-9. doi: 10.1038/cdd.2011.5. Epub 2011 Feb 11.

21.

Evidence of direct cell-cell fusion in Borrelia by cryogenic electron tomography.

Kudryashev M, Cyrklaff M, Alex B, Lemgruber L, Baumeister W, Wallich R, Frischknecht F.

Cell Microbiol. 2011 May;13(5):731-41. doi: 10.1111/j.1462-5822.2011.01571.x. Epub 2011 Jan 30.

PMID:
21276171
22.

Complement factor H-related proteins CFHR2 and CFHR5 represent novel ligands for the infection-associated CRASP proteins of Borrelia burgdorferi.

Siegel C, Hallström T, Skerka C, Eberhardt H, Uzonyi B, Beckhaus T, Karas M, Wallich R, Stevenson B, Zipfel PF, Kraiczy P.

PLoS One. 2010 Oct 20;5(10):e13519. doi: 10.1371/journal.pone.0013519.

23.

Inadequate binding of immune regulator factor H is associated with sensitivity of Borrelia lusitaniae to human complement.

Dieterich R, Hammerschmidt C, Richter D, Skerka C, Wallich R, Matuschka FR, Zipfel PF, Kraiczy P.

Infect Immun. 2010 Nov;78(11):4467-76. doi: 10.1128/IAI.00138-10. Epub 2010 Sep 7.

24.

Effects of low concentrated BMP-7 administered by co-cultivation or plasmid transfection on human osteoarthritic chondrocytes.

Gavenis K, Schneider U, Wallich R, Mueller-Rath R, Schmidt-Rohlfing B, Andereya S.

Int J Artif Organs. 2010 Jun;33(6):339-47.

PMID:
20669139
25.

Complement regulator-acquiring surface protein 1 of Borrelia burgdorferi binds to human bone morphogenic protein 2, several extracellular matrix proteins, and plasminogen.

Hallström T, Haupt K, Kraiczy P, Hortschansky P, Wallich R, Skerka C, Zipfel PF.

J Infect Dis. 2010 Aug 15;202(3):490-8. doi: 10.1086/653825.

PMID:
20565259
26.

Human complement regulators C4b-binding protein and C1 esterase inhibitor interact with a novel outer surface protein of Borrelia recurrentis.

Grosskinsky S, Schott M, Brenner C, Cutler SJ, Simon MM, Wallich R.

PLoS Negl Trop Dis. 2010 Jun 1;4(6):e698. doi: 10.1371/journal.pntd.0000698.

27.

Granzyme B-induced and caspase 3-dependent cleavage of gelsolin by mouse cytotoxic T cells modifies cytoskeleton dynamics.

Martin P, Pardo J, Schill N, Jöckel L, Berg M, Froelich CJ, Wallich R, Simon MM.

J Biol Chem. 2010 Jun 11;285(24):18918-27. doi: 10.1074/jbc.M109.056028. Epub 2010 Apr 15.

28.

Molecular characterization of the interaction of Borrelia parkeri and Borrelia turicatae with human complement regulators.

Schott M, Grosskinsky S, Brenner C, Kraiczy P, Wallich R.

Infect Immun. 2010 May;78(5):2199-208. doi: 10.1128/IAI.00089-10. Epub 2010 Mar 15.

29.

Granzyme B of cytotoxic T cells induces extramitochondrial reactive oxygen species production via caspase-dependent NADPH oxidase activation.

Aguiló JI, Anel A, Catalán E, Sebastián A, Acín-Pérez R, Naval J, Wallich R, Simon MM, Pardo J.

Immunol Cell Biol. 2010 Jul;88(5):545-54. doi: 10.1038/icb.2010.5. Epub 2010 Feb 2.

PMID:
20125115
30.

Functional characterization of Borrelia spielmanii outer surface proteins that interact with distinct members of the human factor H protein family and with plasminogen.

Seling A, Siegel C, Fingerle V, Jutras BL, Brissette CA, Skerka C, Wallich R, Zipfel PF, Stevenson B, Kraiczy P.

Infect Immun. 2010 Jan;78(1):39-48. doi: 10.1128/IAI.00691-09. Epub 2009 Oct 26.

31.

Distinct in situ structures of the Borrelia flagellar motor.

Kudryashev M, Cyrklaff M, Wallich R, Baumeister W, Frischknecht F.

J Struct Biol. 2010 Jan;169(1):54-61. doi: 10.1016/j.jsb.2009.08.008. Epub 2009 Aug 21.

PMID:
19699799
32.

Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation.

Heinen S, Hartmann A, Lauer N, Wiehl U, Dahse HM, Schirmer S, Gropp K, Enghardt T, Wallich R, Hälbich S, Mihlan M, Schlötzer-Schrehardt U, Zipfel PF, Skerka C.

Blood. 2009 Sep 17;114(12):2439-47. doi: 10.1182/blood-2009-02-205641. Epub 2009 Jun 15.

PMID:
19528535
33.

Acid sphingomyelinase is a key regulator of cytotoxic granule secretion by primary T lymphocytes.

Herz J, Pardo J, Kashkar H, Schramm M, Kuzmenkina E, Bos E, Wiegmann K, Wallich R, Peters PJ, Herzig S, Schmelzer E, Krönke M, Simon MM, Utermöhlen O.

Nat Immunol. 2009 Jul;10(7):761-8. doi: 10.1038/ni.1757. Epub 2009 Jun 14.

PMID:
19525969
34.

Borrelia recurrentis employs a novel multifunctional surface protein with anti-complement, anti-opsonic and invasive potential to escape innate immunity.

Grosskinsky S, Schott M, Brenner C, Cutler SJ, Kraiczy P, Zipfel PF, Simon MM, Wallich R.

PLoS One. 2009;4(3):e4858. doi: 10.1371/journal.pone.0004858. Epub 2009 Mar 24.

35.

The biology of cytotoxic cell granule exocytosis pathway: granzymes have evolved to induce cell death and inflammation.

Pardo J, Aguilo JI, Anel A, Martin P, Joeckel L, Borner C, Wallich R, Müllbacher A, Froelich CJ, Simon MM.

Microbes Infect. 2009 Apr;11(4):452-9. doi: 10.1016/j.micinf.2009.02.004. Epub 2009 Feb 26. Review.

PMID:
19249384
36.

Comparative cryo-electron tomography of pathogenic Lyme disease spirochetes.

Kudryashev M, Cyrklaff M, Baumeister W, Simon MM, Wallich R, Frischknecht F.

Mol Microbiol. 2009 Mar;71(6):1415-34. doi: 10.1111/j.1365-2958.2009.06613.x. Epub 2009 Feb 4.

37.

Mutational analyses of the BbCRASP-1 protein of Borrelia burgdorferi identify residues relevant for the architecture and binding of host complement regulators FHL-1 and factor H.

Kraiczy P, Hanssen-Hübner C, Kitiratschky V, Brenner C, Besier S, Brade V, Simon MM, Skerka C, Roversi P, Lea SM, Stevenson B, Wallich R, Zipfel PF.

Int J Med Microbiol. 2009 Apr;299(4):255-68. doi: 10.1016/j.ijmm.2008.09.002. Epub 2009 Jan 9.

PMID:
19138559
38.

[Lyme borreliosis: research gaps and research approaches. Results from an interdisciplinary expert meeting at the Robert Koch Institute].

Poggensee G, Fingerle V, Hunfeld KP, Kraiczy P, Krause A, Matuschka FR, Richter D, Simon MM, Wallich R, Hofman H, Kohn B, Lierz M, Linde A, Schneider T, Straubinger R, Stark K, Süss J, Talaska T, Jansen A.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Nov;51(11):1329-39. doi: 10.1007/s00103-008-0703-6. German.

PMID:
19043762
39.

Borrelia burgdorferi infection-associated surface proteins ErpP, ErpA, and ErpC bind human plasminogen.

Brissette CA, Haupt K, Barthel D, Cooley AE, Bowman A, Skerka C, Wallich R, Zipfel PF, Kraiczy P, Stevenson B.

Infect Immun. 2009 Jan;77(1):300-6. doi: 10.1128/IAI.01133-08. Epub 2008 Nov 10.

40.

Human and mouse granzyme A induce a proinflammatory cytokine response.

Metkar SS, Menaa C, Pardo J, Wang B, Wallich R, Freudenberg M, Kim S, Raja SM, Shi L, Simon MM, Froelich CJ.

Immunity. 2008 Nov 14;29(5):720-33. doi: 10.1016/j.immuni.2008.08.014. Epub 2008 Oct 23.

41.

Deciphering the ligand-binding sites in the Borrelia burgdorferi complement regulator-acquiring surface protein 2 required for interactions with the human immune regulators factor H and factor H-like protein 1.

Siegel C, Schreiber J, Haupt K, Skerka C, Brade V, Simon MM, Stevenson B, Wallich R, Zipfel PF, Kraiczy P.

J Biol Chem. 2008 Dec 12;283(50):34855-63. doi: 10.1074/jbc.M805844200. Epub 2008 Sep 29.

42.

Identification and characterization of the factor H and FHL-1 binding complement regulator-acquiring surface protein 1 of the Lyme disease spirochete Borrelia spielmanii sp. nov.

Herzberger P, Siegel C, Skerka C, Fingerle V, Schulte-Spechtel U, Wilske B, Brade V, Zipfel PF, Wallich R, Kraiczy P.

Int J Med Microbiol. 2009 Feb;299(2):141-54. doi: 10.1016/j.ijmm.2008.06.005. Epub 2008 Aug 15.

PMID:
18706858
43.

Borrelia burgdorferi complement regulator-acquiring surface proteins (BbCRASPs): Expression patterns during the mammal-tick infection cycle.

Bykowski T, Woodman ME, Cooley AE, Brissette CA, Wallich R, Brade V, Kraiczy P, Stevenson B.

Int J Med Microbiol. 2008 Sep 1;298 Suppl 1:249-56. doi: 10.1016/j.ijmm.2007.10.002. Epub 2007 Dec 31. Review.

44.

Borrelia burgdorferi complement regulator-acquiring surface protein 2 (CspZ) as a serological marker of human Lyme disease.

Kraiczy P, Seling A, Brissette CA, Rossmann E, Hunfeld KP, Bykowski T, Burns LH, Troese MJ, Cooley AE, Miller JC, Brade V, Wallich R, Casjens S, Stevenson B.

Clin Vaccine Immunol. 2008 Mar;15(3):484-91. Epub 2007 Dec 26.

45.

Granzyme B-induced cell death exerted by ex vivo CTL: discriminating requirements for cell death and some of its signs.

Pardo J, Wallich R, Martin P, Urban C, Rongvaux A, Flavell RA, Müllbacher A, Borner C, Simon MM.

Cell Death Differ. 2008 Mar;15(3):567-79. Epub 2007 Dec 7.

46.

Development of hepatitis B virus capsids into a whole-chain protein antigen display platform: new particulate Lyme disease vaccines.

Nassal M, Skamel C, Vogel M, Kratz PA, Stehle T, Wallich R, Simon MM.

Int J Med Microbiol. 2008 Jan;298(1-2):135-42. Epub 2007 Sep 20. Review.

PMID:
17888729
47.

Human pathogenic Borrelia spielmanii sp. nov. resists complement-mediated killing by direct binding of immune regulators factor H and factor H-like protein 1.

Herzberger P, Siegel C, Skerka C, Fingerle V, Schulte-Spechtel U, van Dam A, Wilske B, Brade V, Zipfel PF, Wallich R, Kraiczy P.

Infect Immun. 2007 Oct;75(10):4817-25. Epub 2007 Jul 16.

48.

Granzyme B is expressed in mouse mast cells in vivo and in vitro and causes delayed cell death independent of perforin.

Pardo J, Wallich R, Ebnet K, Iden S, Zentgraf H, Martin P, Ekiciler A, Prins A, Müllbacher A, Huber M, Simon MM.

Cell Death Differ. 2007 Oct;14(10):1768-79. Epub 2007 Jun 29.

49.

Coordinated expression of Borrelia burgdorferi complement regulator-acquiring surface proteins during the Lyme disease spirochete's mammal-tick infection cycle.

Bykowski T, Woodman ME, Cooley AE, Brissette CA, Brade V, Wallich R, Kraiczy P, Stevenson B.

Infect Immun. 2007 Sep;75(9):4227-36. Epub 2007 Jun 11.

50.

Binding of human factor H-related protein 1 to serum-resistant Borrelia burgdorferi is mediated by borrelial complement regulator-acquiring surface proteins.

Haupt K, Kraiczy P, Wallich R, Brade V, Skerka C, Zipfel PF.

J Infect Dis. 2007 Jul 1;196(1):124-33. Epub 2007 May 23.

PMID:
17538892

Supplemental Content

Loading ...
Support Center